ARS Pharmaceuticals, a company located in San Diego, CA, United States, is AsMA’s most recent Corporate Member. Their goal is to develop easy-to-use, patient friendly treatments for allergies to allow treatment at the first sign of symptoms. They are advised by a scientific advisory board. They recently announced their adrenaline nasal spray had been recommended for approval in the European Union for the treatment of Type 1 allergic reactions. They also exhibited at the 2026 American Academy of Allergy, Asthma and Immunology that took place in late February through early March.

—Please visit https://ars-pharma.com/ to read more about this company.